Study Finds GLP-1 Drug Users Show Decreased Physical Activity Levels
By
Ed Cara
Summary
A new study presented by doctors at HSHS Saint John's Hospital in Illinois found that people taking GLP-1 drugs like Ozempic and Wegovy significantly decreased their physical activity levels after starting the medication, based on Fitbit data from people with obesity. While GLP-1 drugs have transformed weight loss treatment, the preliminary findings suggest patients may become less inclined to maintain other healthy habits like exercise, highlighting the need for promoting physical activity alongside medication use.
Source
bskyStudy Finds GLP-1 Drug Users Show Decreased Physical Activity Levelsgizmodo.comKey quotes
· 3 pulledGLP-1 drugs like semaglutide (the active ingredient in Ozempic and Wegovy) have changed weight loss treatment for the better.
People's level of physical activity significantly decreased after starting a GLP-1, they found.
Though preliminary, the study's findings suggest that promoting exercise should be emphasized alongside medication.
You might also wanna read
Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients
A study analyzing over 6,800 colon cancer patients across University of California Health sites found that patients taking GLP-1 medications
Experts warn easy access to GLP-1 drugs may increase eating disorder risks
Experts are raising concerns that the widespread availability of GLP-1 drugs (like Ozempic and Wegovy) through telemedicine and oral formula
mdsc.pe·1d ago
Study: Ozempic and Wegovy Reduce Household Food Spending and Change Purchasing Patterns
New research published in the Journal of Marketing Research shows that GLP-1 receptor agonist drugs like Ozempic and Wegovy are significantl
news.cornell.edu·5mo ago
What Happens When You Stop Taking GLP-1 Weight Loss Medications
This article examines the experiences of people who stop taking GLP-1 weight loss medications (like Ozempic and Wegovy), exploring what happ
bbc.com·6mo ago
Study: Stopping GLP-1 Drugs Increases Heart Attack and Stroke Risk
New research published in BMJ Medicine reveals that stopping GLP-1 drugs (originally for diabetes, now popular for weight loss) leads to a r
nautil.us·3mo ago
GLP-1 Medications Show Promise for Treating Addiction Through Brain Reward Pathways
The article explores the emerging potential of GLP-1 medications like Ozempic to treat various addictions beyond their original diabetes and
newyorker.com·4mo ago